nodes	percent_of_prediction	percent_of_DWPC	metapath
Saquinavir—ABCG2—Leflunomide—systemic scleroderma	0.0689	0.0952	CbGbCtD
Saquinavir—CYP2C8—Mometasone—systemic scleroderma	0.057	0.0787	CbGbCtD
Saquinavir—SLCO1B1—Mycophenolate mofetil—systemic scleroderma	0.0536	0.0741	CbGbCtD
Saquinavir—ABCC2—Mycophenolate mofetil—systemic scleroderma	0.0471	0.0651	CbGbCtD
Saquinavir—SLCO1A2—Prednisone—systemic scleroderma	0.0454	0.0628	CbGbCtD
Saquinavir—ABCG2—Mycophenolate mofetil—systemic scleroderma	0.0426	0.0588	CbGbCtD
Saquinavir—ALB—Captopril—systemic scleroderma	0.0373	0.0515	CbGbCtD
Saquinavir—ALB—Mycophenolate mofetil—systemic scleroderma	0.0294	0.0406	CbGbCtD
Saquinavir—ABCB1—Lisinopril—systemic scleroderma	0.0261	0.036	CbGbCtD
Saquinavir—CYP2C9—Leflunomide—systemic scleroderma	0.0256	0.0354	CbGbCtD
Saquinavir—ABCC1—Methotrexate—systemic scleroderma	0.0255	0.0353	CbGbCtD
Saquinavir—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0236	0.0326	CbGbCtD
Saquinavir—ALB—Prednisone—systemic scleroderma	0.0235	0.0324	CbGbCtD
Saquinavir—SLCO1A2—Methotrexate—systemic scleroderma	0.0228	0.0315	CbGbCtD
Saquinavir—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0227	0.0313	CbGbCtD
Saquinavir—SLCO1B1—Methotrexate—systemic scleroderma	0.0215	0.0297	CbGbCtD
Saquinavir—ABCB1—Captopril—systemic scleroderma	0.0195	0.027	CbGbCtD
Saquinavir—ABCC2—Methotrexate—systemic scleroderma	0.0189	0.0261	CbGbCtD
Saquinavir—CYP2D6—Captopril—systemic scleroderma	0.0184	0.0254	CbGbCtD
Saquinavir—ABCG2—Methotrexate—systemic scleroderma	0.0171	0.0236	CbGbCtD
Saquinavir—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0154	0.0212	CbGbCtD
Saquinavir—CYP2C19—Prednisone—systemic scleroderma	0.0152	0.021	CbGbCtD
Saquinavir—ABCB1—Prednisone—systemic scleroderma	0.0123	0.017	CbGbCtD
Saquinavir—ALB—Methotrexate—systemic scleroderma	0.0118	0.0163	CbGbCtD
Saquinavir—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0092	0.0127	CbGbCtD
Saquinavir—CYP3A4—Prednisone—systemic scleroderma	0.00736	0.0102	CbGbCtD
Saquinavir—ABCB1—Methotrexate—systemic scleroderma	0.00616	0.00851	CbGbCtD
Saquinavir—Liver function test abnormal—Methotrexate—systemic scleroderma	0.000112	0.000407	CcSEcCtD
Saquinavir—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000112	0.000406	CcSEcCtD
Saquinavir—Depression—Prednisone—systemic scleroderma	0.000112	0.000406	CcSEcCtD
Saquinavir—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.000112	0.000405	CcSEcCtD
Saquinavir—Urticaria—Leflunomide—systemic scleroderma	0.000112	0.000404	CcSEcCtD
Saquinavir—Abdominal pain—Leflunomide—systemic scleroderma	0.000111	0.000402	CcSEcCtD
Saquinavir—Body temperature increased—Leflunomide—systemic scleroderma	0.000111	0.000402	CcSEcCtD
Saquinavir—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.00011	0.0004	CcSEcCtD
Saquinavir—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.00011	0.000399	CcSEcCtD
Saquinavir—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.00011	0.000399	CcSEcCtD
Saquinavir—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.00011	0.000399	CcSEcCtD
Saquinavir—Neuropathy peripheral—Prednisone—systemic scleroderma	0.00011	0.000399	CcSEcCtD
Saquinavir—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00011	0.000398	CcSEcCtD
Saquinavir—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00011	0.000398	CcSEcCtD
Saquinavir—Hypersensitivity—Azathioprine—systemic scleroderma	0.00011	0.000397	CcSEcCtD
Saquinavir—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00011	0.000397	CcSEcCtD
Saquinavir—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00011	0.000396	CcSEcCtD
Saquinavir—Insomnia—Lisinopril—systemic scleroderma	0.000109	0.000395	CcSEcCtD
Saquinavir—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000109	0.000394	CcSEcCtD
Saquinavir—Paraesthesia—Lisinopril—systemic scleroderma	0.000108	0.000392	CcSEcCtD
Saquinavir—Vomiting—Captopril—systemic scleroderma	0.000108	0.000392	CcSEcCtD
Saquinavir—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000108	0.00039	CcSEcCtD
Saquinavir—Dyspnoea—Lisinopril—systemic scleroderma	0.000108	0.000389	CcSEcCtD
Saquinavir—Rash—Captopril—systemic scleroderma	0.000107	0.000389	CcSEcCtD
Saquinavir—Dermatitis—Captopril—systemic scleroderma	0.000107	0.000389	CcSEcCtD
Saquinavir—Somnolence—Lisinopril—systemic scleroderma	0.000107	0.000388	CcSEcCtD
Saquinavir—Headache—Captopril—systemic scleroderma	0.000107	0.000386	CcSEcCtD
Saquinavir—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000107	0.000386	CcSEcCtD
Saquinavir—Dyspepsia—Lisinopril—systemic scleroderma	0.000106	0.000385	CcSEcCtD
Saquinavir—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000106	0.000383	CcSEcCtD
Saquinavir—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000106	0.000383	CcSEcCtD
Saquinavir—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000106	0.000383	CcSEcCtD
Saquinavir—Asthma—Methotrexate—systemic scleroderma	0.000105	0.000381	CcSEcCtD
Saquinavir—Infection—Mycophenolate mofetil—systemic scleroderma	0.000105	0.00038	CcSEcCtD
Saquinavir—Decreased appetite—Lisinopril—systemic scleroderma	0.000105	0.00038	CcSEcCtD
Saquinavir—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000104	0.000377	CcSEcCtD
Saquinavir—Fatigue—Lisinopril—systemic scleroderma	0.000104	0.000377	CcSEcCtD
Saquinavir—Shock—Mycophenolate mofetil—systemic scleroderma	0.000104	0.000377	CcSEcCtD
Saquinavir—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000104	0.000375	CcSEcCtD
Saquinavir—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000103	0.000375	CcSEcCtD
Saquinavir—Hypersensitivity—Leflunomide—systemic scleroderma	0.000103	0.000375	CcSEcCtD
Saquinavir—Pancreatitis—Methotrexate—systemic scleroderma	0.000103	0.000374	CcSEcCtD
Saquinavir—Pain—Lisinopril—systemic scleroderma	0.000103	0.000374	CcSEcCtD
Saquinavir—Constipation—Lisinopril—systemic scleroderma	0.000103	0.000374	CcSEcCtD
Saquinavir—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000103	0.000372	CcSEcCtD
Saquinavir—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000102	0.00037	CcSEcCtD
Saquinavir—Diarrhoea—Azathioprine—systemic scleroderma	0.000102	0.000368	CcSEcCtD
Saquinavir—Haemoglobin—Prednisone—systemic scleroderma	0.000101	0.000367	CcSEcCtD
Saquinavir—Nausea—Captopril—systemic scleroderma	0.000101	0.000366	CcSEcCtD
Saquinavir—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000101	0.000366	CcSEcCtD
Saquinavir—Haemorrhage—Prednisone—systemic scleroderma	0.000101	0.000365	CcSEcCtD
Saquinavir—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000101	0.000365	CcSEcCtD
Saquinavir—Asthenia—Leflunomide—systemic scleroderma	0.000101	0.000365	CcSEcCtD
Saquinavir—Hallucination—Prednisone—systemic scleroderma	0.0001	0.000363	CcSEcCtD
Saquinavir—Pancytopenia—Methotrexate—systemic scleroderma	0.0001	0.000362	CcSEcCtD
Saquinavir—Feeling abnormal—Lisinopril—systemic scleroderma	9.94e-05	0.00036	CcSEcCtD
Saquinavir—Pruritus—Leflunomide—systemic scleroderma	9.93e-05	0.00036	CcSEcCtD
Saquinavir—Connective tissue disorder—Prednisone—systemic scleroderma	9.91e-05	0.000359	CcSEcCtD
Saquinavir—Hypotension—Mycophenolate mofetil—systemic scleroderma	9.88e-05	0.000358	CcSEcCtD
Saquinavir—Gastrointestinal pain—Lisinopril—systemic scleroderma	9.87e-05	0.000357	CcSEcCtD
Saquinavir—Neutropenia—Methotrexate—systemic scleroderma	9.85e-05	0.000357	CcSEcCtD
Saquinavir—Dizziness—Azathioprine—systemic scleroderma	9.83e-05	0.000356	CcSEcCtD
Saquinavir—Upper respiratory tract infection—Methotrexate—systemic scleroderma	9.79e-05	0.000354	CcSEcCtD
Saquinavir—Erectile dysfunction—Methotrexate—systemic scleroderma	9.7e-05	0.000351	CcSEcCtD
Saquinavir—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	9.63e-05	0.000349	CcSEcCtD
Saquinavir—Photosensitivity reaction—Methotrexate—systemic scleroderma	9.61e-05	0.000348	CcSEcCtD
Saquinavir—Asthenia—Mycophenolic acid—systemic scleroderma	9.61e-05	0.000348	CcSEcCtD
Saquinavir—Diarrhoea—Leflunomide—systemic scleroderma	9.61e-05	0.000348	CcSEcCtD
Saquinavir—Urticaria—Lisinopril—systemic scleroderma	9.58e-05	0.000347	CcSEcCtD
Saquinavir—Insomnia—Mycophenolate mofetil—systemic scleroderma	9.56e-05	0.000346	CcSEcCtD
Saquinavir—Abdominal pain—Lisinopril—systemic scleroderma	9.54e-05	0.000345	CcSEcCtD
Saquinavir—Body temperature increased—Lisinopril—systemic scleroderma	9.54e-05	0.000345	CcSEcCtD
Saquinavir—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	9.49e-05	0.000344	CcSEcCtD
Saquinavir—Pruritus—Mycophenolic acid—systemic scleroderma	9.48e-05	0.000343	CcSEcCtD
Saquinavir—Vomiting—Azathioprine—systemic scleroderma	9.45e-05	0.000342	CcSEcCtD
Saquinavir—Pneumonia—Methotrexate—systemic scleroderma	9.44e-05	0.000342	CcSEcCtD
Saquinavir—Eye disorder—Prednisone—systemic scleroderma	9.43e-05	0.000341	CcSEcCtD
Saquinavir—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	9.42e-05	0.000341	CcSEcCtD
Saquinavir—Somnolence—Mycophenolate mofetil—systemic scleroderma	9.4e-05	0.00034	CcSEcCtD
Saquinavir—Infestation NOS—Methotrexate—systemic scleroderma	9.39e-05	0.00034	CcSEcCtD
Saquinavir—Infestation—Methotrexate—systemic scleroderma	9.39e-05	0.00034	CcSEcCtD
Saquinavir—Rash—Azathioprine—systemic scleroderma	9.37e-05	0.000339	CcSEcCtD
Saquinavir—Dermatitis—Azathioprine—systemic scleroderma	9.37e-05	0.000339	CcSEcCtD
Saquinavir—Depression—Methotrexate—systemic scleroderma	9.36e-05	0.000339	CcSEcCtD
Saquinavir—Headache—Azathioprine—systemic scleroderma	9.31e-05	0.000337	CcSEcCtD
Saquinavir—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	9.31e-05	0.000337	CcSEcCtD
Saquinavir—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	9.3e-05	0.000337	CcSEcCtD
Saquinavir—Dizziness—Leflunomide—systemic scleroderma	9.28e-05	0.000336	CcSEcCtD
Saquinavir—Renal failure—Methotrexate—systemic scleroderma	9.23e-05	0.000334	CcSEcCtD
Saquinavir—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	9.19e-05	0.000333	CcSEcCtD
Saquinavir—Diarrhoea—Mycophenolic acid—systemic scleroderma	9.16e-05	0.000332	CcSEcCtD
Saquinavir—Stomatitis—Methotrexate—systemic scleroderma	9.15e-05	0.000331	CcSEcCtD
Saquinavir—Angiopathy—Prednisone—systemic scleroderma	9.15e-05	0.000331	CcSEcCtD
Saquinavir—Conjunctivitis—Methotrexate—systemic scleroderma	9.13e-05	0.00033	CcSEcCtD
Saquinavir—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	9.13e-05	0.00033	CcSEcCtD
Saquinavir—Immune system disorder—Prednisone—systemic scleroderma	9.11e-05	0.00033	CcSEcCtD
Saquinavir—Pain—Mycophenolate mofetil—systemic scleroderma	9.04e-05	0.000327	CcSEcCtD
Saquinavir—Constipation—Mycophenolate mofetil—systemic scleroderma	9.04e-05	0.000327	CcSEcCtD
Saquinavir—Vomiting—Leflunomide—systemic scleroderma	8.93e-05	0.000323	CcSEcCtD
Saquinavir—Alopecia—Prednisone—systemic scleroderma	8.91e-05	0.000323	CcSEcCtD
Saquinavir—Hypersensitivity—Lisinopril—systemic scleroderma	8.89e-05	0.000322	CcSEcCtD
Saquinavir—Hepatobiliary disease—Methotrexate—systemic scleroderma	8.88e-05	0.000322	CcSEcCtD
Saquinavir—Dizziness—Mycophenolic acid—systemic scleroderma	8.86e-05	0.000321	CcSEcCtD
Saquinavir—Epistaxis—Methotrexate—systemic scleroderma	8.86e-05	0.000321	CcSEcCtD
Saquinavir—Rash—Leflunomide—systemic scleroderma	8.85e-05	0.000321	CcSEcCtD
Saquinavir—Dermatitis—Leflunomide—systemic scleroderma	8.84e-05	0.00032	CcSEcCtD
Saquinavir—Mental disorder—Prednisone—systemic scleroderma	8.84e-05	0.00032	CcSEcCtD
Saquinavir—Nausea—Azathioprine—systemic scleroderma	8.83e-05	0.00032	CcSEcCtD
Saquinavir—Headache—Leflunomide—systemic scleroderma	8.8e-05	0.000318	CcSEcCtD
Saquinavir—Malnutrition—Prednisone—systemic scleroderma	8.78e-05	0.000318	CcSEcCtD
Saquinavir—Erythema—Prednisone—systemic scleroderma	8.78e-05	0.000318	CcSEcCtD
Saquinavir—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	8.71e-05	0.000315	CcSEcCtD
Saquinavir—Asthenia—Lisinopril—systemic scleroderma	8.66e-05	0.000313	CcSEcCtD
Saquinavir—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	8.64e-05	0.000313	CcSEcCtD
Saquinavir—Pruritus—Lisinopril—systemic scleroderma	8.54e-05	0.000309	CcSEcCtD
Saquinavir—Vomiting—Mycophenolic acid—systemic scleroderma	8.52e-05	0.000308	CcSEcCtD
Saquinavir—Haemoglobin—Methotrexate—systemic scleroderma	8.47e-05	0.000307	CcSEcCtD
Saquinavir—Rash—Mycophenolic acid—systemic scleroderma	8.45e-05	0.000306	CcSEcCtD
Saquinavir—Dermatitis—Mycophenolic acid—systemic scleroderma	8.44e-05	0.000305	CcSEcCtD
Saquinavir—Haemorrhage—Methotrexate—systemic scleroderma	8.43e-05	0.000305	CcSEcCtD
Saquinavir—Hepatitis—Methotrexate—systemic scleroderma	8.43e-05	0.000305	CcSEcCtD
Saquinavir—Urticaria—Mycophenolate mofetil—systemic scleroderma	8.4e-05	0.000304	CcSEcCtD
Saquinavir—Headache—Mycophenolic acid—systemic scleroderma	8.39e-05	0.000304	CcSEcCtD
Saquinavir—Pharyngitis—Methotrexate—systemic scleroderma	8.37e-05	0.000303	CcSEcCtD
Saquinavir—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	8.36e-05	0.000303	CcSEcCtD
Saquinavir—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	8.36e-05	0.000303	CcSEcCtD
Saquinavir—Nausea—Leflunomide—systemic scleroderma	8.34e-05	0.000302	CcSEcCtD
Saquinavir—Urinary tract disorder—Methotrexate—systemic scleroderma	8.32e-05	0.000301	CcSEcCtD
Saquinavir—Urethral disorder—Methotrexate—systemic scleroderma	8.26e-05	0.000299	CcSEcCtD
Saquinavir—Diarrhoea—Lisinopril—systemic scleroderma	8.25e-05	0.000299	CcSEcCtD
Saquinavir—Ill-defined disorder—Prednisone—systemic scleroderma	8.15e-05	0.000295	CcSEcCtD
Saquinavir—Visual impairment—Methotrexate—systemic scleroderma	8.12e-05	0.000294	CcSEcCtD
Saquinavir—Anaemia—Prednisone—systemic scleroderma	8.11e-05	0.000294	CcSEcCtD
Saquinavir—Agitation—Prednisone—systemic scleroderma	8.07e-05	0.000292	CcSEcCtD
Saquinavir—Dizziness—Lisinopril—systemic scleroderma	7.98e-05	0.000289	CcSEcCtD
Saquinavir—Erythema multiforme—Methotrexate—systemic scleroderma	7.97e-05	0.000289	CcSEcCtD
Saquinavir—Nausea—Mycophenolic acid—systemic scleroderma	7.96e-05	0.000288	CcSEcCtD
Saquinavir—Malaise—Prednisone—systemic scleroderma	7.92e-05	0.000287	CcSEcCtD
Saquinavir—Vertigo—Prednisone—systemic scleroderma	7.89e-05	0.000286	CcSEcCtD
Saquinavir—Eye disorder—Methotrexate—systemic scleroderma	7.88e-05	0.000285	CcSEcCtD
Saquinavir—Syncope—Prednisone—systemic scleroderma	7.87e-05	0.000285	CcSEcCtD
Saquinavir—Tinnitus—Methotrexate—systemic scleroderma	7.86e-05	0.000285	CcSEcCtD
Saquinavir—Cardiac disorder—Methotrexate—systemic scleroderma	7.82e-05	0.000283	CcSEcCtD
Saquinavir—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	7.79e-05	0.000282	CcSEcCtD
Saquinavir—Loss of consciousness—Prednisone—systemic scleroderma	7.72e-05	0.000279	CcSEcCtD
Saquinavir—Vomiting—Lisinopril—systemic scleroderma	7.67e-05	0.000278	CcSEcCtD
Saquinavir—Angiopathy—Methotrexate—systemic scleroderma	7.65e-05	0.000277	CcSEcCtD
Saquinavir—Immune system disorder—Methotrexate—systemic scleroderma	7.61e-05	0.000276	CcSEcCtD
Saquinavir—Rash—Lisinopril—systemic scleroderma	7.61e-05	0.000275	CcSEcCtD
Saquinavir—Convulsion—Prednisone—systemic scleroderma	7.61e-05	0.000275	CcSEcCtD
Saquinavir—Dermatitis—Lisinopril—systemic scleroderma	7.6e-05	0.000275	CcSEcCtD
Saquinavir—Mediastinal disorder—Methotrexate—systemic scleroderma	7.6e-05	0.000275	CcSEcCtD
Saquinavir—Asthenia—Mycophenolate mofetil—systemic scleroderma	7.58e-05	0.000275	CcSEcCtD
Saquinavir—Hypertension—Prednisone—systemic scleroderma	7.58e-05	0.000274	CcSEcCtD
Saquinavir—Chills—Methotrexate—systemic scleroderma	7.56e-05	0.000274	CcSEcCtD
Saquinavir—Headache—Lisinopril—systemic scleroderma	7.56e-05	0.000274	CcSEcCtD
Saquinavir—Pruritus—Mycophenolate mofetil—systemic scleroderma	7.48e-05	0.000271	CcSEcCtD
Saquinavir—Myalgia—Prednisone—systemic scleroderma	7.47e-05	0.000271	CcSEcCtD
Saquinavir—Arthralgia—Prednisone—systemic scleroderma	7.47e-05	0.000271	CcSEcCtD
Saquinavir—Anxiety—Prednisone—systemic scleroderma	7.45e-05	0.00027	CcSEcCtD
Saquinavir—Alopecia—Methotrexate—systemic scleroderma	7.45e-05	0.00027	CcSEcCtD
Saquinavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	7.42e-05	0.000269	CcSEcCtD
Saquinavir—Discomfort—Prednisone—systemic scleroderma	7.38e-05	0.000267	CcSEcCtD
Saquinavir—Mental disorder—Methotrexate—systemic scleroderma	7.38e-05	0.000267	CcSEcCtD
Saquinavir—Erythema—Methotrexate—systemic scleroderma	7.34e-05	0.000266	CcSEcCtD
Saquinavir—Malnutrition—Methotrexate—systemic scleroderma	7.34e-05	0.000266	CcSEcCtD
Saquinavir—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	7.23e-05	0.000262	CcSEcCtD
Saquinavir—Dysgeusia—Methotrexate—systemic scleroderma	7.19e-05	0.00026	CcSEcCtD
Saquinavir—Nausea—Lisinopril—systemic scleroderma	7.17e-05	0.000259	CcSEcCtD
Saquinavir—Oedema—Prednisone—systemic scleroderma	7.17e-05	0.000259	CcSEcCtD
Saquinavir—Infection—Prednisone—systemic scleroderma	7.12e-05	0.000258	CcSEcCtD
Saquinavir—Back pain—Methotrexate—systemic scleroderma	7.1e-05	0.000257	CcSEcCtD
Saquinavir—Shock—Prednisone—systemic scleroderma	7.05e-05	0.000255	CcSEcCtD
Saquinavir—Nervous system disorder—Prednisone—systemic scleroderma	7.03e-05	0.000254	CcSEcCtD
Saquinavir—Dizziness—Mycophenolate mofetil—systemic scleroderma	6.99e-05	0.000253	CcSEcCtD
Saquinavir—Skin disorder—Prednisone—systemic scleroderma	6.96e-05	0.000252	CcSEcCtD
Saquinavir—Hyperhidrosis—Prednisone—systemic scleroderma	6.93e-05	0.000251	CcSEcCtD
Saquinavir—Anorexia—Prednisone—systemic scleroderma	6.83e-05	0.000247	CcSEcCtD
Saquinavir—Ill-defined disorder—Methotrexate—systemic scleroderma	6.81e-05	0.000246	CcSEcCtD
Saquinavir—Anaemia—Methotrexate—systemic scleroderma	6.78e-05	0.000246	CcSEcCtD
Saquinavir—Vomiting—Mycophenolate mofetil—systemic scleroderma	6.72e-05	0.000243	CcSEcCtD
Saquinavir—Rash—Mycophenolate mofetil—systemic scleroderma	6.67e-05	0.000241	CcSEcCtD
Saquinavir—Dermatitis—Mycophenolate mofetil—systemic scleroderma	6.66e-05	0.000241	CcSEcCtD
Saquinavir—Headache—Mycophenolate mofetil—systemic scleroderma	6.62e-05	0.00024	CcSEcCtD
Saquinavir—Malaise—Methotrexate—systemic scleroderma	6.62e-05	0.00024	CcSEcCtD
Saquinavir—Vertigo—Methotrexate—systemic scleroderma	6.59e-05	0.000239	CcSEcCtD
Saquinavir—Leukopenia—Methotrexate—systemic scleroderma	6.57e-05	0.000238	CcSEcCtD
Saquinavir—Musculoskeletal discomfort—Prednisone—systemic scleroderma	6.53e-05	0.000236	CcSEcCtD
Saquinavir—Insomnia—Prednisone—systemic scleroderma	6.48e-05	0.000235	CcSEcCtD
Saquinavir—Paraesthesia—Prednisone—systemic scleroderma	6.43e-05	0.000233	CcSEcCtD
Saquinavir—Cough—Methotrexate—systemic scleroderma	6.4e-05	0.000232	CcSEcCtD
Saquinavir—Convulsion—Methotrexate—systemic scleroderma	6.36e-05	0.00023	CcSEcCtD
Saquinavir—Dyspepsia—Prednisone—systemic scleroderma	6.31e-05	0.000228	CcSEcCtD
Saquinavir—Nausea—Mycophenolate mofetil—systemic scleroderma	6.28e-05	0.000227	CcSEcCtD
Saquinavir—Arthralgia—Methotrexate—systemic scleroderma	6.25e-05	0.000226	CcSEcCtD
Saquinavir—Myalgia—Methotrexate—systemic scleroderma	6.25e-05	0.000226	CcSEcCtD
Saquinavir—Chest pain—Methotrexate—systemic scleroderma	6.25e-05	0.000226	CcSEcCtD
Saquinavir—Decreased appetite—Prednisone—systemic scleroderma	6.23e-05	0.000226	CcSEcCtD
Saquinavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	6.2e-05	0.000225	CcSEcCtD
Saquinavir—Fatigue—Prednisone—systemic scleroderma	6.18e-05	0.000224	CcSEcCtD
Saquinavir—Discomfort—Methotrexate—systemic scleroderma	6.17e-05	0.000223	CcSEcCtD
Saquinavir—Constipation—Prednisone—systemic scleroderma	6.13e-05	0.000222	CcSEcCtD
Saquinavir—Confusional state—Methotrexate—systemic scleroderma	6.04e-05	0.000219	CcSEcCtD
Saquinavir—Infection—Methotrexate—systemic scleroderma	5.95e-05	0.000215	CcSEcCtD
Saquinavir—Feeling abnormal—Prednisone—systemic scleroderma	5.9e-05	0.000214	CcSEcCtD
Saquinavir—Nervous system disorder—Methotrexate—systemic scleroderma	5.87e-05	0.000213	CcSEcCtD
Saquinavir—Thrombocytopenia—Methotrexate—systemic scleroderma	5.86e-05	0.000212	CcSEcCtD
Saquinavir—Gastrointestinal pain—Prednisone—systemic scleroderma	5.86e-05	0.000212	CcSEcCtD
Saquinavir—Skin disorder—Methotrexate—systemic scleroderma	5.82e-05	0.000211	CcSEcCtD
Saquinavir—Hyperhidrosis—Methotrexate—systemic scleroderma	5.79e-05	0.00021	CcSEcCtD
Saquinavir—Anorexia—Methotrexate—systemic scleroderma	5.71e-05	0.000207	CcSEcCtD
Saquinavir—Urticaria—Prednisone—systemic scleroderma	5.69e-05	0.000206	CcSEcCtD
Saquinavir—Body temperature increased—Prednisone—systemic scleroderma	5.66e-05	0.000205	CcSEcCtD
Saquinavir—Abdominal pain—Prednisone—systemic scleroderma	5.66e-05	0.000205	CcSEcCtD
Saquinavir—Hypotension—Methotrexate—systemic scleroderma	5.6e-05	0.000203	CcSEcCtD
Saquinavir—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	5.46e-05	0.000198	CcSEcCtD
Saquinavir—Insomnia—Methotrexate—systemic scleroderma	5.42e-05	0.000196	CcSEcCtD
Saquinavir—Paraesthesia—Methotrexate—systemic scleroderma	5.38e-05	0.000195	CcSEcCtD
Saquinavir—Dyspnoea—Methotrexate—systemic scleroderma	5.34e-05	0.000193	CcSEcCtD
Saquinavir—Somnolence—Methotrexate—systemic scleroderma	5.32e-05	0.000193	CcSEcCtD
Saquinavir—Hypersensitivity—Prednisone—systemic scleroderma	5.28e-05	0.000191	CcSEcCtD
Saquinavir—Dyspepsia—Methotrexate—systemic scleroderma	5.27e-05	0.000191	CcSEcCtD
Saquinavir—Decreased appetite—Methotrexate—systemic scleroderma	5.21e-05	0.000188	CcSEcCtD
Saquinavir—Gastrointestinal disorder—Methotrexate—systemic scleroderma	5.17e-05	0.000187	CcSEcCtD
Saquinavir—Fatigue—Methotrexate—systemic scleroderma	5.16e-05	0.000187	CcSEcCtD
Saquinavir—Asthenia—Prednisone—systemic scleroderma	5.14e-05	0.000186	CcSEcCtD
Saquinavir—Pain—Methotrexate—systemic scleroderma	5.12e-05	0.000185	CcSEcCtD
Saquinavir—Pruritus—Prednisone—systemic scleroderma	5.07e-05	0.000184	CcSEcCtD
Saquinavir—Feeling abnormal—Methotrexate—systemic scleroderma	4.93e-05	0.000179	CcSEcCtD
Saquinavir—Diarrhoea—Prednisone—systemic scleroderma	4.9e-05	0.000178	CcSEcCtD
Saquinavir—Gastrointestinal pain—Methotrexate—systemic scleroderma	4.9e-05	0.000177	CcSEcCtD
Saquinavir—Urticaria—Methotrexate—systemic scleroderma	4.76e-05	0.000172	CcSEcCtD
Saquinavir—Dizziness—Prednisone—systemic scleroderma	4.74e-05	0.000172	CcSEcCtD
Saquinavir—Abdominal pain—Methotrexate—systemic scleroderma	4.73e-05	0.000171	CcSEcCtD
Saquinavir—Body temperature increased—Methotrexate—systemic scleroderma	4.73e-05	0.000171	CcSEcCtD
Saquinavir—Vomiting—Prednisone—systemic scleroderma	4.56e-05	0.000165	CcSEcCtD
Saquinavir—Rash—Prednisone—systemic scleroderma	4.52e-05	0.000164	CcSEcCtD
Saquinavir—Dermatitis—Prednisone—systemic scleroderma	4.51e-05	0.000163	CcSEcCtD
Saquinavir—Headache—Prednisone—systemic scleroderma	4.49e-05	0.000163	CcSEcCtD
Saquinavir—Hypersensitivity—Methotrexate—systemic scleroderma	4.41e-05	0.00016	CcSEcCtD
Saquinavir—Asthenia—Methotrexate—systemic scleroderma	4.3e-05	0.000156	CcSEcCtD
Saquinavir—Nausea—Prednisone—systemic scleroderma	4.26e-05	0.000154	CcSEcCtD
Saquinavir—Pruritus—Methotrexate—systemic scleroderma	4.24e-05	0.000153	CcSEcCtD
Saquinavir—Diarrhoea—Methotrexate—systemic scleroderma	4.1e-05	0.000148	CcSEcCtD
Saquinavir—Dizziness—Methotrexate—systemic scleroderma	3.96e-05	0.000143	CcSEcCtD
Saquinavir—Vomiting—Methotrexate—systemic scleroderma	3.81e-05	0.000138	CcSEcCtD
Saquinavir—Rash—Methotrexate—systemic scleroderma	3.78e-05	0.000137	CcSEcCtD
Saquinavir—Dermatitis—Methotrexate—systemic scleroderma	3.77e-05	0.000137	CcSEcCtD
Saquinavir—Headache—Methotrexate—systemic scleroderma	3.75e-05	0.000136	CcSEcCtD
Saquinavir—Nausea—Methotrexate—systemic scleroderma	3.56e-05	0.000129	CcSEcCtD
